Position in XNCR
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$5,767,486
+$1,581,726 QoQ
Shares Held
358,229
+3.2% QoQ
Ownership
0.482%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 208 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XNCR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRINCIPAL FINANCIAL GROUP INC holds $1,852,088,599 across 105 Biotechnology names. XNCR ranks #43 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
873,502 | $232,980,453 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
389,511 | $193,481,798 | |
| 3 | CYTK |
Cytokinetics Inc
|
1,311,664 | $111,740,655 | |
| 4 | GPCR |
Structure Therapeutics Inc.
|
1,752,753 | $94,070,253 | |
| 5 | INSM |
INSMED Inc
|
856,126 | $91,280,154 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
332,642 | $81,420,782 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
1,024,423 | $76,299,024 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
121,053 | $75,481,386 |
All Filings in XNCR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,767,486 | 358,229 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $4,185,760 | 347,078 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $5,210,390 | 340,326 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $4,040,468 | 344,456 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $2,773,313 | 352,839 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $3,710,444 | 348,726 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $7,816,531 | 340,145 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $5,870,430 | 291,916 | Shares | Defined | 2024-10-31 | |
| 2024-06-30 | $5,814,670 | 307,167 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $7,162,706 | 323,665 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $7,260,872 | 342,010 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $6,974,257 | 346,117 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $8,977,912 | 359,548 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $10,493,806 | 376,257 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $9,948,894 | 382,062 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $9,721,585 | 374,195 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $10,229,755 | 373,758 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $10,742,754 | 402,652 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $16,277,766 | 405,727 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $13,746,463 | 420,896 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $14,659,766 | 425,044 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $18,193,021 | 422,504 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $18,347,723 | 420,530 | Shares | Defined | 2021-02-23 | |
| 2020-09-30 | $16,658,248 | 429,447 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $12,691,534 | 391,835 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $11,442,097 | 382,935 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||